PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Semler Scientific, Inc. (SMLR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US81684M1045

CUSIP

81684M104

Sector

Healthcare

IPO Date

Feb 21, 2014

Highlights

Market Cap

$501.10M

EPS (TTM)

$5.13

PE Ratio

10.18

Total Revenue (TTM)

$56.29M

Gross Profit (TTM)

$51.53M

EBITDA (TTM)

$20.93M

Year Range

$20.88 - $81.56

Target Price

$71.00

Short %

22.31%

Short Ratio

3.59

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
SMLR vs. MSTR SMLR vs. VOO SMLR vs. SPY SMLR vs. RIOT SMLR vs. BTC-USD SMLR vs. ARE SMLR vs. NVDA SMLR vs. MSTY SMLR vs. GME SMLR vs. SCHG
Popular comparisons:
SMLR vs. MSTR SMLR vs. VOO SMLR vs. SPY SMLR vs. RIOT SMLR vs. BTC-USD SMLR vs. ARE SMLR vs. NVDA SMLR vs. MSTY SMLR vs. GME SMLR vs. SCHG

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Semler Scientific, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%150.00%SeptemberOctoberNovemberDecember2025February
84.46%
10.29%
SMLR (Semler Scientific, Inc.)
Benchmark (^GSPC)

Returns By Period

Semler Scientific, Inc. had a return of -3.30% year-to-date (YTD) and 9.25% in the last 12 months. Over the past 10 years, Semler Scientific, Inc. had an annualized return of 28.54%, outperforming the S&P 500 benchmark which had an annualized return of 11.26%.


SMLR

YTD

-3.30%

1M

-19.26%

6M

77.80%

1Y

9.25%

5Y*

-0.55%

10Y*

28.54%

^GSPC (Benchmark)

YTD

4.01%

1M

1.13%

6M

9.82%

1Y

22.80%

5Y*

12.93%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of SMLR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-3.78%-3.30%
20240.00%6.50%-38.08%-12.60%14.88%17.29%-3.63%-19.46%-11.80%24.76%94.08%-5.30%21.92%
202318.82%-43.89%21.82%4.78%-2.10%-4.55%-6.44%7.37%-3.76%14.98%32.12%14.92%34.21%
2022-17.44%-3.53%-32.11%-7.20%-39.42%1.15%10.11%47.31%-17.85%11.88%-29.45%11.34%-63.99%
2021-5.45%13.11%6.93%5.35%-2.87%1.63%5.56%-10.17%17.95%19.96%-35.74%-4.91%-2.50%
2020-1.04%11.58%-24.72%13.91%-6.95%8.77%20.65%-4.05%0.26%6.76%27.19%29.66%95.83%
201915.84%4.77%2.44%4.63%-1.65%-0.70%19.15%-15.92%-4.07%11.90%-8.51%11.63%39.53%
2018-3.13%7.10%5.42%-0.46%40.64%26.12%31.00%25.99%39.61%-4.21%-16.72%21.13%330.00%
201772.41%8.00%-7.41%10.00%14.55%-1.59%6.45%-0.30%29.18%55.29%7.58%12.68%451.72%
2016-3.91%-22.76%8.42%-24.86%21.14%-26.93%50.36%-11.65%-6.59%-4.12%-11.04%0.00%-43.36%
2015144.39%-14.41%-14.63%0.00%-3.71%-4.16%3.72%-6.27%-7.64%20.34%-49.00%43.82%30.61%
2014-0.57%-24.75%-5.35%-3.23%-13.78%-15.98%-0.57%-12.18%-28.71%36.57%-33.56%-71.96%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SMLR is 49, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of SMLR is 4949
Overall Rank
The Sharpe Ratio Rank of SMLR is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of SMLR is 5353
Sortino Ratio Rank
The Omega Ratio Rank of SMLR is 5252
Omega Ratio Rank
The Calmar Ratio Rank of SMLR is 4646
Calmar Ratio Rank
The Martin Ratio Rank of SMLR is 4646
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Semler Scientific, Inc. (SMLR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for SMLR, currently valued at 0.01, compared to the broader market-2.000.002.000.011.74
The chart of Sortino ratio for SMLR, currently valued at 0.80, compared to the broader market-4.00-2.000.002.004.006.000.802.36
The chart of Omega ratio for SMLR, currently valued at 1.10, compared to the broader market0.501.001.502.001.101.32
The chart of Calmar ratio for SMLR, currently valued at 0.02, compared to the broader market0.002.004.006.000.022.62
The chart of Martin ratio for SMLR, currently valued at 0.04, compared to the broader market-10.000.0010.0020.0030.000.0410.69
SMLR
^GSPC

The current Semler Scientific, Inc. Sharpe ratio is 0.01. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Semler Scientific, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.01
1.74
SMLR (Semler Scientific, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Semler Scientific, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-65.18%
0
SMLR (Semler Scientific, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Semler Scientific, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Semler Scientific, Inc. was 87.15%, occurring on Mar 17, 2023. The portfolio has not yet recovered.

The current Semler Scientific, Inc. drawdown is 65.18%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.15%Nov 1, 2021346Mar 17, 2023
-80.57%Feb 27, 2014541Jun 29, 2016242Nov 1, 2017783
-44.5%Feb 25, 202020Mar 23, 202091Jul 31, 2020111
-28.84%Oct 4, 201837Nov 26, 201837Jan 22, 201974
-27.6%Aug 1, 201949Oct 9, 201990Feb 19, 2020139

Volatility

Volatility Chart

The current Semler Scientific, Inc. volatility is 17.35%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%SeptemberOctoberNovemberDecember2025February
17.35%
3.07%
SMLR (Semler Scientific, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Semler Scientific, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Semler Scientific, Inc. compared to its peers in the Medical Devices industry.


PE Ratio
100.0200.0300.010.2
The chart displays the price to earnings (P/E) ratio for SMLR in comparison to other companies of the Medical Devices industry. Currently, SMLR has a PE value of 10.2. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
-60.0-40.0-20.00.020.040.060.080.00.0
The chart displays the price to earnings to growth (PEG) ratio for SMLR in comparison to other companies of the Medical Devices industry. Currently, SMLR has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Semler Scientific, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab